We are live on ! Find out more
AVDL

Avadel Pharmaceuticals

Delisted

AVDL was delisted on the 11th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
RI
1
RTW Investments
New York
$46.4M
CAC
2
Cowen and Company
New York
$30.2M +$11M +1,207,326 +48%
VC
3
Vivo Capital
California
$23.7M
PCH
4
Polar Capital Holdings
United Kingdom
$22.6M
BIP
5
Brandes Investment Partners
California
$21M -$5.92M -647,652 -20%
GJL
6
Gendell Jeffrey L
$19.8M +$3.54M +387,529 +19%
WE
7
Wealth Effects
Massachusetts
$18.6M +$21.1M +2,305,017 New
WP
8
Woodline Partners
California
$18.3M +$4.9M +535,942 +31%
ACA
9
Avoro Capital Advisors
New York
$13.5M -$5.53M -605,000 -27%
Janus Henderson Group
10
Janus Henderson Group
$8.12M +$1.76M +192,061 +24%
FM
11
Frazier Management
Washington
$7.69M
Renaissance Technologies
12
Renaissance Technologies
New York
$6.83M -$68.5K -7,500 -0.9%
SB
13
Samsara BioCapital
California
$5.33M +$1.01M +110,159 +20%
Morgan Stanley
14
Morgan Stanley
New York
$3.69M +$302K +33,044 +8%
ACM
15
Altium Capital Management
New York
$3.56M
MB
16
MPM BioImpact
Massachusetts
$3.03M -$226K -24,674 -6%
ACM
17
Asymmetry Capital Management
California
$2.98M -$962K -105,234 -22%
Deutsche Bank
18
Deutsche Bank
Germany
$2.77M
DMKJ
19
David M. Knott Jr
$2.09M +$2.36M +258,198 New
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$1.77M -$1.56M -171,056 -44%
CM
21
Caption Management
Oklahoma
$1.54M +$366K +40,000 +27%
State Street
22
State Street
Massachusetts
$1.53M +$226K +24,732 +15%
CIBC Private Wealth Group
23
CIBC Private Wealth Group
Georgia
$1.34M
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$1.29M +$1.46M +160,206 New
Lazard Asset Management
25
Lazard Asset Management
New York
$1.27M +$905K +98,965 +169%